Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial
Titel:
Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial
Auteur:
Lorusso, D. Scambia, G. Pignata, S. Sorio, R. Amadio, G. Lepori, S. Mosconi, A. Pisano, C. Mangili, G. Maltese, G. Sabbatini, R. Artioli, G. Gamucci, T. Di Napoli, M. Capoluongo, E. Ludovini, V. Raspagliesi, F. Ferrandina, G.